SOCAZOLIMAB
UNII 82P4S8Q3FB

Substance Identification & Data

This profile provides standardized clinical and technical data for Socazolimab, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 82P4S8Q3FB.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2305043-30-3 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

82P4S8Q3FB

CAS Registry Number

2305043-30-3

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

SOCAZOLIMAB

Official standardized name for this substance within the FDA UNII nomenclature system.

NCI Thesaurus

C162504

National Cancer Institute reference terminology for clinical and research data.

INN ID

11672

Sequential identifier assigned via the WHO International Nonproprietary Name program.

USAN ID

GH-198

Identifier assigned by the United States Adopted Names Council.

Substance Type

protein

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Socazolimab. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

SOCAZOLIMAB

Common Names & Synonyms

IMMUNOGLOBULIN G1, ANTI-(HUMAN PROGRAMMED DEATH-LIGAND 1) (HUMAN MONOCLONAL ZKAB001 .GAMMA.1-CHAIN), DISULFIDE WITH HUMAN MONOCLONAL ZKAB001 .LAMBDA.-CHAIN, DIMER

IMMUNOGLOBULIN G1-LAMBDA2, ANTI-(HOMO SAPIENS CD274 (PROGRAMMED CELL DEATH 1 LIGAND 1, B7H1, B7-H1, PDL1, PD-L1, PDCD1L1, B7 HOMOLOG 1)), MONOCLONAL ANTIBODY; GAMMA1 HEAVY CHAIN (1-449) (VH (HOMO SAPIENS IGHV1-69*01 (98.0%)-(IGHD)-IGHJ6*01 (94.7%), CDR-IMGT (8.8.12) (26-33.51-58.97-108)) (1-119)-HOMO SAPIENS IGHG1*01 (100%), G1M17,1 (CH1 K120 (216) (120-217), HINGE 1-15 (218-232), CH2 (233-342), CH3 D12 (358), L14 (360) (343-447), CHS (448-449)) (120-449)), (222-214')-DISULFIDE WITH LAMBDA2 LIGHT CHAIN (1'-215') (V-LAMBDA (HOMO SAPIENS IGLV2-23*02 (90.8%)-IGLJ2*01 (100%), CDR-IMGT (9.3.10) (26-34.52-54.90-99)) (1'-109')-HOMO SAPIENS IGLC2*01 (100%) (110'-215')); DIMER (228-228'':231-231'')-BISDISULFIDE, PRODUCED IN CHINESE HAMSTER OVARY (CHO)-K1SV CELL LINE LACKING THE GLUTAMINE SYNTHETASE GENE (GSKO), GLYCOFORM ALFA

SOCAZOLIMAB [INN]

SOCAZOLIMAB [USAN]

SOCAZOLIMAB [WHO-DD]